These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3719368)

  • 1. Agonist and inhibitory effects of pyridostigmine at the neuromuscular junction.
    Bradley RJ; Sterz R; Peper K
    Brain Res; 1986 Jun; 376(1):199-203. PubMed ID: 3719368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex.
    Albuquerque EX; Akaike A; Shaw KP; Rickett DL
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S27-33. PubMed ID: 6327444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
    Rang HP; Rylett RJ
    Br J Pharmacol; 1984 Mar; 81(3):519-31. PubMed ID: 6141831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echothiophate and cogeners decrease the voltage dependence of end-plate current decay in frog skeletal muscle.
    Henderson EG; Post-Munson DJ; Reynolds LS; Epstein PM
    J Pharmacol Exp Ther; 1989 Dec; 251(3):810-6. PubMed ID: 2481033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of dose-response curves by quantitative ionophoresis at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R
    J Physiol; 1978 Aug; 281():395-419. PubMed ID: 309003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anticholinesterases and of sodium fluoride on neuromyal desensitization.
    Akasu T; Karczmar AG
    Neuropharmacology; 1980 Apr; 19(4):393-403. PubMed ID: 6966767
    [No Abstract]   [Full Text] [Related]  

  • 7. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
    Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
    Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anticholinesterase drugs on the ionophoretically-evoked end-plate currents.
    Scuka M
    Pflugers Arch; 1987 Nov; 410(4-5):428-32. PubMed ID: 3501570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversal by pyridostigmine of neuromuscular block produced by soman.
    French MC; Wetherell JR; White PD
    J Pharm Pharmacol; 1979 May; 31(5):290-4. PubMed ID: 37297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between nerve-related acetylcholine and bath applied agonists at the frog end-plate.
    Feltz A; Trautmann A
    J Physiol; 1980 Feb; 299():533-52. PubMed ID: 6966689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A kinetic analysis of the endplate ion channel blocking action of disopyramide and its optical isomers.
    Dempster J; Jones SV; Marshall IG
    Br J Pharmacol; 1987 Feb; 90(2):299-307. PubMed ID: 2435351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversal potential at the desensitized endplate.
    Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1977 Nov; 199(1135):329-34. PubMed ID: 22862
    [No Abstract]   [Full Text] [Related]  

  • 13. Desensitization of the post-synaptic membrane of neuromuscular synapses induced by spontaneous quantum secretion of mediator.
    Giniatullin RA; Magazanik LG
    Neurosci Behav Physiol; 1998; 28(4):438-42. PubMed ID: 9762720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A re-examination of curare action at the motor endplate.
    Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1978 Dec; 203(1151):119-33. PubMed ID: 33387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
    Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
    Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine is an antagonist of the acetylcholine receptor at the frog endplate.
    Ariyoshi M; Hasuo H; Koketsu K; Ohta Y; Tokimasa T
    Br J Pharmacol; 1985 May; 85(1):65-73. PubMed ID: 4027473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox.
    Dionne VE; Stevens CF
    J Physiol; 1975 Oct; 251(2):245-70. PubMed ID: 1081139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical concentrations of edrophonium enhance desensitization of the nicotinic acetylcholine receptor.
    Yost CS; Maestrone E
    Anesth Analg; 1994 Mar; 78(3):520-6. PubMed ID: 8109771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of the neuromuscular junction to chronic acetylcholinesterase inhibition due to phospholine treatment.
    Faff J; Bak W
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):293-301. PubMed ID: 7271388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
    Frick CG; Helming M; Martyn JA; Blobner M; Fink H
    Crit Care Med; 2010 Mar; 38(3):922-7. PubMed ID: 20009758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.